Log in
Show password
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 


Business Summary
Century Therapeutics, Inc. is a biotechnology company. The Company is focused on developing transformative allogeneic, pluripotent stem cells (iPSC)-derived natural killer (NK) and T cell therapies to create products for the treatment of both solid tumor and hematological malignancies. Its Allo-Evasion technology is intended to prevent rejection of cell products by the host immune system, and manufacturing capabilities intended to minimize product development and supply risk. The Company's pipeline includes CNTY-101, CNTY-103, CNTY-102 and CNTY-104. The Company’s lead product candidate, CNTY-101, is focused on targeting B-cell lymphoma. CNTY-103 is designed to treat glioblastoma. CNTY-102 is designed to further improve B-cell malignancy treatment. CNTY-104, is being developed to treat acute myeloid leukemia (AML). In addition to its programs, the Company is also actively engaged in a number of earlier stage discovery programs.
Name Title Age Since
Osvaldo Flores, Dr. Chief Executive Officer & Director - -
Douglas Carr Vice President-Finance & Operations - 2018
Hyam I. Levitsky, Dr. President-Research & Development 63 2019
Cynthia M. Butitta Independent Director 66 2021
Mike C. Diem, Dr. Chief Business Officer 51 -
Members of the board
Name Title Age Since
Joseph Jimenez Chairman 61 2021
Osvaldo Flores, Dr. Chief Executive Officer & Director - -
Carlo Rizzuto, Dr. Director 51 -
Toshikazu Ban Director 60 -
Jak Knowles, Dr. Director - -
Eli D. Casdin Director 48 2021
Cynthia M. Butitta Independent Director 66 2021
Versant Venture Management LLC 13,259,905 24.3%
Bayer Aktiengesellschaft 12,675,838 23.2%
FUJIFILM Holdings Corporation 6,955,207 12.7%
Fidelity Management & Research Co. LLC 6,312,260 11.6%
Casdin Capital LLC 3,206,380 5.87%
SB Management Ltd. (AE) 2,000,000 3.66%
Osvaldo Flores 1,321,719 2.42%
Federated Global Investment Management Corp. 1,164,094 2.13%
RA Capital Management LP 914,094 1.67%
Avidity Partners Management LP 739,269 1.35%
Company contact information
Century Therapeutics, Inc.
3675 Market Street
Philadelphia, PA 19104

Web : http://www.centurytherapeutics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Century Therapeutics, Inc.